Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quidelortho Corp (QDEL)

Quidelortho Corp (QDEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,340,298
  • Shares Outstanding, K 67,932
  • Annual Sales, $ 2,783 M
  • Annual Income, $ -2,052 M
  • EBIT $ 18 M
  • EBITDA $ 2,294 M
  • 60-Month Beta 0.35
  • Price/Sales 0.50
  • Price/Cash Flow 0.60
  • Price/Book 0.71

Options Overview Details

View History
  • Implied Volatility 82.42% ( +24.07%)
  • Historical Volatility 87.13%
  • IV Percentile 90%
  • IV Rank 71.87%
  • IV High 98.77% on 04/17/25
  • IV Low 40.65% on 12/09/24
  • Put/Call Vol Ratio 0.20
  • Today's Volume 119
  • Volume Avg (30-Day) 212
  • Put/Call OI Ratio 0.51
  • Today's Open Interest 9,527
  • Open Int (30-Day) 7,520

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.92
  • Number of Estimates 3
  • High Estimate 1.04
  • Low Estimate 0.76
  • Prior Year 0.63
  • Growth Rate Est. (year over year) +46.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.58 +0.77%
on 11/10/25
30.85 -36.05%
on 10/23/25
-6.64 (-25.18%)
since 10/10/25
3-Month
19.58 +0.77%
on 11/10/25
32.81 -39.87%
on 10/03/25
-4.18 (-17.48%)
since 08/08/25
52-Week
19.58 +0.77%
on 11/10/25
49.45 -60.10%
on 01/07/25
-24.02 (-54.90%)
since 11/08/24

Most Recent Stories

More News
Why QuidelOrtho (QDEL) Stock Is Down Today

Why QuidelOrtho (QDEL) Stock Is Down Today

QDEL : 19.73 (-3.05%)
QDEL Q3 Deep Dive: Margin Progress and Cost Actions Offset Headwinds in Core Diagnostics

QDEL Q3 Deep Dive: Margin Progress and Cost Actions Offset Headwinds in Core Diagnostics

QDEL : 19.73 (-3.05%)
QuidelOrtho: Q3 Earnings Snapshot

QuidelOrtho: Q3 Earnings Snapshot

QDEL : 19.73 (-3.05%)
QuidelOrtho (NASDAQ:QDEL) Beats Q3 Sales Expectations

QuidelOrtho (NASDAQ:QDEL) Beats Q3 Sales Expectations

QDEL : 19.73 (-3.05%)
QuidelOrtho Reports Third Quarter 2025 Financial Results

―  Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ―

QDEL : 19.73 (-3.05%)
QuidelOrtho (QDEL) Q3 Earnings: What To Expect

QuidelOrtho (QDEL) Q3 Earnings: What To Expect

QDEL : 19.73 (-3.05%)
QuidelOrtho Receives FDA 510(k) Clearance for VITROSâ„¢ Immunodiagnostic Products hs Troponin I Assay

Clearance expands menu and enables high-sensitivity troponin I measurement to aid in the diagnosis of myocardial infarction

QDEL : 19.73 (-3.05%)
Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

SAN DIEGO , Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 52 of its Science Bytes podcast, featuring George...

QDEL : 19.73 (-3.05%)
1 Small-Cap Stock with Exciting Potential and 2 We Avoid

1 Small-Cap Stock with Exciting Potential and 2 We Avoid

TFSL : 13.83 (+0.29%)
QDEL : 19.73 (-3.05%)
SYBT : 67.37 (+0.64%)
QuidelOrtho to Report Third Quarter 2025 Financial Results

SAN DIEGO , Oct. 22, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, announced today that it will report its...

QDEL : 19.73 (-3.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is below 30%. The market is in oversold territory. Watch for a potential trend reversal.

See More Share

Business Summary

QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases,...

See More

Key Turning Points

3rd Resistance Point 22.10
2nd Resistance Point 21.56
1st Resistance Point 20.65
Last Price 19.73
1st Support Level 19.20
2nd Support Level 18.66
3rd Support Level 17.75

See More

52-Week High 49.45
Fibonacci 61.8% 38.04
Fibonacci 50% 34.52
Fibonacci 38.2% 30.99
Last Price 19.73
52-Week Low 19.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar